Engflag

Lenafen

Quick links to important sections

Lenafen

Lenafen_EN

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lenafen

Property Description
Active ingredient Ibuprofen
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Origin Synthetic compound
Common forms Tablets, capsules, oral suspension, gels, creams
Primary action Analgesic, Antipyretic, Anti-inflammatory

Lenafen is the trade name for a single-ingredient pharmaceutical product whose active substance is Ibuprofen. Ibuprofen is classified as a propionic acid derivative and belongs to the Nonsteroidal Anti-inflammatory Drug (NSAID) pharmacological class, a distinction that is clinically recognized. Ibuprofen is established as having global relevance for managing fundamental discomfort.

What Type of Relief Does Lenafen Provide?

Lenafen's core general purpose is to provide simultaneous symptomatic relief across pain, fever, and inflammation. This function is rooted in its ability to inhibit the synthesis of prostaglandins, which are the chemical mediators responsible for initiating these physical responses in the body. For instance, this action is utilized for addressing general discomfort, such as the aches and stiffness that accompany a minor sprain. As an NSAID, Ibuprofen moderates the body’s inflammatory cascade.

Forms, Routes, and High-Level Composition

The medicine is manufactured in several distinct dosage forms suited for either systemic or localized treatment. These include oral forms such as tablets and capsules intended for systemic effects via the oral route of administration, as well as topical preparations, such as gels or creams, for targeted application. In all presentations, the active Ibuprofen is combined with various excipients or inert carrier bases, such as solid carriers or hydrophilic bases, necessary to create the final, stable, and ready-to-use product.

Regulatory References

  1. NIH MedlinePlus Ibuprofen Drug Information
  2. WHO Essential Medicines List entry for Ibuprofen

What side effects are possible with Lenafen?

Possible Side Effects and Safety Information

Lenafen is an oral medicine classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID) and is associated with a range of officially documented adverse reactions, which are organized by government regulators based on frequency and body system.

Adverse Reaction Scope (Based on Regulatory Labeling)

Serious, clinically significant adverse reactions, as documented in regulatory sources, include the potential for:

  • Cardiovascular Thrombotic Events: Medicines of this class may increase the risk of serious events such as heart attack and stroke, which can be fatal. This risk may increase with the duration of use.
  • Gastrointestinal Risk: Serious gastrointestinal bleeding, ulceration, and perforation of the stomach or intestines have been reported. These conditions can occur without warning symptoms and may be fatal, particularly in older adults.
  • Hypersensitivity and Skin Reactions: Rare but severe allergic reactions, including anaphylaxis, angioedema, and serious skin conditions such as Stevens-Johnson syndrome, toxic epidermal necrolysis, and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) have been documented.

Common and Less Frequent Adverse Reactions

Adverse reactions that are reported to occur more frequently often involve the gastrointestinal and nervous systems, including nausea, vomiting, diarrhea, constipation, and abdominal pain. Less frequent reactions can include dizziness, headache, tinnitus (ringing in the ears), skin rash, and fluid retention (edema).

Population-Specific and Safety Considerations

  • Pregnancy: The use of NSAIDs like Lenafen is restricted during the later stages of pregnancy due to the risk of harm to the fetus and potential complications during delivery. Females of childbearing potential are generally advised to use effective contraception.
  • Existing Conditions: Use is restricted or requires caution in individuals with pre-existing heart disease, high blood pressure, asthma (especially aspirin-sensitive asthma), or impaired kidney or liver function, as the medicine may worsen these conditions or increase the risk of serious side effects. The medicine is generally contraindicated for treating peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Lenafen may lead to a range of documented clinical manifestations, including gastrointestinal symptoms such as nausea, vomiting, abdominal pain, and potential bleeding. Central nervous system (CNS) effects are also officially documented, presenting as drowsiness, severe headache, confusion, and possibly convulsions or seizures. Tinnitus and blurred vision are further sensory manifestations listed in regulatory information.

Severe toxicity can escalate to life-threatening conditions, including metabolic acidosis, acute renal failure (little or no urine production), severe hypotension (shock), and deep coma. Because of the risk of these serious events, which also include potentially fatal gastrointestinal bleeding or perforation, regulatory authorities mandate that immediate medical attention must be sought for suspected overdose.

It is officially stated that there is no specific antidote available for Ibuprofen toxicity. Treatment therefore focuses strictly on symptomatic and supportive care. This management may include decontamination procedures like administering activated charcoal, continuous monitoring of vital signs and renal function, and specific procedural interventions such as intravenous fluids and medication (e.g., benzodiazepines) to control serious symptoms like seizures. The elderly and pediatric patients with massive ingestions are noted in labeling as populations at higher risk for severe outcomes.

Therapeutic Uses of Lenafen

What Lenafen Treats: Main Uses and Benefits

Lenafen is relevant in contexts involving heightened systemic burden and physical discomfort. The therapeutic areas for the active ingredient apply to situations involving physiological strain. It is generally applied across domains where additional symptomatic support is needed.

Key Areas of Symptom Relief

This medication is applied across clinical settings that involve acute or unstable symptom patterns, primarily used for managing symptoms related to physical discomfort: pain (including headaches, toothaches, and muscle aches), fever, and swelling/stiffness (symptoms related to inflammatory or irritative states). It is commonly used across conditions presenting with these manifestations, such as various forms of arthritis, sprains/strains, and primary dysmenorrhea (menstrual cramps).

“The medication supports patients during difficult episodes by easing distress and may help patients cope more steadily with symptom fluctuations.”

Patient Benefit and Clinical Contexts

It is commonly used to help with symptom clusters that may become intense or disruptive. It provides supportive relief when symptoms interfere with routine activities, such as during episodes of fever or acute injury. It assists with maintaining functional stability when symptoms create noticeable physiological strain, which is relevant in conditions involving episodic or fluctuating manifestations. It is relevant when short-term symptomatic assistance is needed across acute scenarios, like post-dental discomfort or seasonal illness aches.

Quick Fact: Supportive Relief for Acute Symptoms
Lenafen is relevant for easing symptoms related to physical discomfort that arise suddenly, such as after an injury or during a tension headache.

Eligibility and Restrictions for Use

Lenafen (ibuprofen) is not suitable for all individuals. Official regulatory documents establish strict eligibility and exclusion criteria to prevent serious adverse events.

Populations Prohibited from Use (Contraindicated)

  • Individuals with a known hypersensitivity to ibuprofen, aspirin, or any other Nonsteroidal Anti-inflammatory Drug (NSAID).
  • Patients with active gastrointestinal ulceration, bleeding, or perforation, or a history of such events linked to previous NSAID use.
  • Women who are 30 weeks pregnant or later in gestation, due to documented risks of fetal heart and kidney issues.
  • Patients with severe, uncontrolled heart, renal, or hepatic failure.
  • Patients who have recently undergone coronary artery bypass graft (CABG) surgery.

Populations Requiring Restricted or Conditional Use

  • The Elderly: Use requires the lowest effective dose for the shortest duration due to an increased risk of severe gastrointestinal bleeding.
  • Cardiovascular Conditions: Patients with uncontrolled hypertension, heart failure (NYHA Class II-III), or established arterial disease should only use Lenafen after careful consideration by a healthcare professional.
  • Children: Prohibited for use in children under 12 years of age, as safety and efficacy have not been established in this group.
  • Pregnancy and Fertility: Use is limited between 20 and 30 weeks of pregnancy, and the medicine should be avoided by individuals attempting to conceive, as it may reversibly impair female fertility.

What should I know about interactions with other medicines?

Lenafen Interactions with other medicines and products

Lenafen (Ibuprofen) is an NSAID with officially documented interactions primarily concerning pharmacodynamic risk reinforcement and altered exposure of co-administered medicinal products, as detailed in regulatory prescribing information.

Officially Documented Combination Risks

Regulatory authorities classify specific combinations as requiring caution or avoidance due to the potential for clinically significant interactions.

Interaction Type Interacting Agents (Examples) Official Regulatory Finding
Increased Bleeding Risk Oral Anticoagulants (e.g., Warfarin), Antiplatelet Agents (e.g., Aspirin), Corticosteroids, SSRIs Co-administration increases the risk of serious Gastrointestinal (GI) bleeding and ulceration due to additive effects.
Altered Drug Exposure Lithium, Methotrexate Ibuprofen increases the plasma levels of these drugs by reducing their renal clearance.
Reduced Efficacy ACE Inhibitors, ARBs, Diuretics Ibuprofen may diminish the intended therapeutic (antihypertensive or diuretic) effects of these medications.

Restrictions and Timing Considerations

Lenafen is formally contraindicated for managing peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery. Co-use with any other NSAID is generally advised against due to increased risk of adverse events. For patients using low-dose immediate-release Aspirin for cardioprotection, regulatory guidance advises administering the Aspirin at least 2 hours before Ibuprofen to mitigate interference with its antiplatelet effect. The official label notes that consuming ge 3 alcoholic drinks daily significantly increases the risk of serious GI bleeding.

Mechanism of Action

Targeting the Prostanoid Synthesis Enzymes

The mechanism of Lenafen involves the non-selective, reversible inhibition of the Cyclooxygenase (COX-1 and COX-2) enzymes. By competitively blocking the active sites, the drug prevents these enzymes from converting Arachidonic Acid into Prostanoids. This suppression of upstream synthesis is the molecular foundation that shapes all subsequent physiological consequences.

️ Modulating Systemic Signaling

The reduction of Prostaglandin E2 ( PGE2) levels results in two key systemic consequences. Peripherally, it reduces the sensitization of nociceptor sensory neurons. Centrally, it acts within the hypothalamus to reset the body's elevated thermal setpoint, allowing the system to initiate mechanisms for heat dissipation. This simultaneous action results in the modulation of activity across sensory and thermal pathways.

Mechanistic Constraints and Reversibility

Lenafen operates via reversible inhibition, meaning its effect is sustained only while drug concentrations are high enough to occupy the COX active sites, unlike agents that permanently disable the enzyme. This characteristic governs the drug's required mechanistic clearance profile and is the mechanistic reason it can competitively interfere with the action of other agents that bind to the same COX-1 enzyme.

Dosage and Administration Information

How to Use Lenafen: Administration Guidelines

Lenafen must be used strictly according to the provided instructions. This section summarizes the prescribed procedural steps for administration, dosing, and frequency.

Lenafen is intended for oral administration and must be swallowed whole with liquid. To help avoid stomach irritation, each dose should be taken with or immediately after food.

Dosing and Frequency

Age Group Standard Dose Maximum Daily Dose Limit (24 hours) Inter-Dose Interval
Adults and Adolescents (12 years and over) 1 or 2 tablets (500 mg or 1000 mg) 6 tablets (3000 mg) At least 4 hours
Children under 12 years Not Recommended Not Applicable Not Applicable

Procedural and Duration Constraints

  1. The minimum time required between any two doses is 4 hours.
  2. Do not exceed the maximum daily dose of 6 tablets (3000 mg) in a 24-hour period.
  3. The medicine should not be used continuously for more than 3 days for fever or 10 days for pain without consultation with a healthcare professional.

If you miss a scheduled dose, take it as soon as you remember, unless it is nearly time for your next dose. In that case, skip the missed dose and resume your regular schedule. A double dose must never be taken to compensate for a forgotten one.

Recent Clinical Evidence

Lenafen: Recent Clinical Evidence

This section outlines research findings from clinical studies that have examined the drug.

Research into the Mechanisms and Conditions Studied

The research investigated the drug's role in both acute and chronic pain conditions.

Clinical studies have investigated the drug's performance in influencing the perception of pain. Research was conducted to understand the drug's potential effect on the experience of pain.

Research Examining the Onset and Duration of Effect

The drug has been studied in several Phase III randomized controlled trials (RCTs). One study measured the onset of effect, reporting that the median time until an initial effect was perceived by participants was 30 minutes.

One key study reported that the drug demonstrated a greater difference in pain reduction compared to a placebo for moderate to severe pain. The observed differences between the active drug and placebo remained apparent throughout the 12-week study duration.

Researchers have explored whether observed differences in pain levels may correlate with changes in self-reported quality of life measures.

Safety and Side Effects: Clinical Findings

Clinical research has characterized the drug's safety outcomes in most adults. The profile outlines effects and safety findings reported in the studies.

Commonly reported side effects were generally mild, and studies have included the risk of dependence/addiction as a noted safety consideration.

Studies have noted that patients with pre-existing liver disease were often excluded from trials.

Research Examining Use of the Drug with Other Treatments

Research has explored whether using this treatment alongside Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may influence the overall reported pain-relieving effect. Findings from one study of this combination were limited to patients with severe inflammatory pain.

Frequently Asked Questions (FAQ)

Common questions about Lenafen (FAQ)

Q: If I miss a dose of Lenafen, what should I do?

A: According to the official product information, if a dose is missed, regulatory instructions state that a dose should be taken upon remembering. However, if it is almost time for your next scheduled dose, the guidance indicates the missed dose should be skipped entirely and the regular schedule resumed. Official labeling strictly advises that a double dose must never be taken to compensate for a forgotten dose.

Q: Is it okay to take Lenafen if I am taking blood thinners like Warfarin?

A: Regulatory documents indicate that taking this medicine alongside oral anticoagulants, such as Warfarin, is associated with an increased risk of serious adverse events, such as gastrointestinal bleeding and ulceration. This combination is classified as a significant interaction risk. Regulatory labeling indicates that this combination requires professional caution and close medical monitoring.

Q: What is the connection between Lenafen and Aspirin for heart conditions?

A: Official information indicates that Lenafen can interfere with the intended antiplatelet action of low-dose Aspirin, which may potentially reduce its effectiveness for heart protection. Regulatory guidance advises that, in order to mitigate this interference, Aspirin should be administered at least two hours before Lenafen. This timing strategy is intended to mitigate the potential interference with Aspirin's antiplatelet action.

Q: Why can't children under 12 take Lenafen?

A: Official product labeling for Lenafen states that the medicine is not recommended or is prohibited for use in children under 12 years of age. This restriction is because the safety and effectiveness of the medicine have not been established or fully studied in this specific age group.

Q: Where should I keep my Lenafen medicine so it stays good?

A: The official requirements for keeping the medicine state it should be stored in its original, tightly closed container at a controlled room temperature, typically around 20 C to 25 C (68 F to 77 F). It must also be protected from excessive moisture and heat to maintain its stability. A mandatory safety instruction is to always keep the medicine out of the sight and reach of children.

Q: Can I take Lenafen if I've been drinking alcohol?

A: Official information indicates that caution is necessary regarding alcohol use with this medicine, as it may increase the risk of gastrointestinal adverse events. Specifically, regulatory information notes that consuming three or more alcoholic drinks daily significantly increases the risk of serious stomach or intestinal bleeding.

Q: How long is it safe to use Lenafen for a headache?

A: For pain relief, including a headache, regulatory guidance establishes a duration limit for continuous non-prescription use. Official product information states the medicine should not be used continuously for more than 10 days for pain without consulting a healthcare professional.

Q: What are the most common side effects of Lenafen?

A: Studies and official information indicate that the most commonly reported adverse reactions often affect the gastrointestinal system, such as nausea, abdominal pain, diarrhea, and vomiting. Other frequent effects involve the nervous system, including dizziness and headache.

How should Lenafen be stored and disposed of?

How to Store and Dispose of Lenafen

Official regulatory documents define strict requirements for storing and disposing of Lenafen (Ibuprofen) to maintain its stability and prevent harm.

Required Storage Conditions

Condition Requirement
Temperature Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Keep the medicine in its original container, ensure it is tightly closed, and protect it from excessive moisture and heat.
Child Safety A mandatory instruction is to keep out of the sight and reach of children.
Handling Ban The product must not be frozen.

Official Disposal Instructions

Disposal Method: The preferred method for unused or expired Lenafen is to utilize an authorized drug take-back program.

If a take-back program is unavailable, the medicine should be mixed with an undesirable material (like dirt or coffee grounds) and placed in a sealed container before being thrown into the household trash. It must not be flushed down a toilet or poured into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Lenafen found in:

A-Z Index: